ESMO: Merck’s Keytruda pushes for 2nd esophageal cancer nod with first-line survival win chelfand Mon, 09/21/2020 – 12:25
FiercePharmaPolitics—White House, pharma pricing talks fell apart over demand for ‘Trump Cards’: NYT
FiercePharmaPolitics—White House, pharma pricing talks fell apart over demand for ‘Trump Cards’: NYT esagonowsky Mon, 09/21/2020 – 09:51
ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients chelfand Mon, 09/21/2020 – 02:00
ESMO: Roche, after Tecentriq’s ovarian cancer fail, banks hopes on final survival analysis aliu Sun, 09/20/2020 – 07:45
Despite the important advances in research in recent years, the etiopathogenesis of Alzheimer’s disease is still not fully […]
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant […]
Faced with a novel lethal virus, employers have struggled to implement their legal duty to protect staff from […]
Minal Singh describes her career in dermatology as someone else’s fault. “I completed a two week placement during […]
Data shows a range of responses in different tumours
